Cargando…

Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging

Plasma neuronal exosomal levels of pathogenic Alzheimer's disease (AD) proteins, cellular survival factors, and lysosomal proteins distinguish AD patients from control subjects, but changes in these exosomal proteins associated with normal aging have not been described for cognitively intact su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abner, Erin L., Jicha, Gregory A., Shaw, Leslie M., Trojanowski, John Q., Goetzl, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863753/ https://www.ncbi.nlm.nih.gov/pubmed/27231710 http://dx.doi.org/10.1002/acn3.309

Ejemplares similares

Low neural exosomal levels of cellular survival factors in Alzheimer’s disease
por: Goetzl, Edward J, et al.
Publicado: (2015)

Novel window on early human neurodevelopment via fetal exosomes in maternal blood
por: Goetzl, Laura, et al.
Publicado: (2016)

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
por: Toledo, Jon B, et al.
Publicado: (2013)

A New Normal? Continued Impact of COVID19 on Alzheimer’s Clinical Trials Research
por: Rhodus, Elizabeth, et al.
Publicado: (2021)

Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia
por: Winston, Charisse N., et al.
Publicado: (2019)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Normalization of CSF pTau measurement by Aβ(40) improves its performance as a biomarker of Alzheimer’s disease
por: Guo, Tengfei, et al.
Publicado: (2020)

Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19
por: Goetzl, Edward J., et al.
Publicado: (2023)

Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease
por: Brown, Christopher A, et al.
Publicado: (2016)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

Role of Cerebrospinal Fluid Biomarkers in Clinical Trials for Alzheimer's Disease Modifying Therapies
por: Kang, Ju-Hee, et al.
Publicado: (2014)

Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder
por: Goetzl, Edward J., et al.
Publicado: (2021)

Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy
por: Goetzl, Edward J., et al.
Publicado: (2019)

COVID-19 and the neurological disease therapeutic pipeline
por: Jicha, Gregory A., et al.
Publicado: (2020)

Altered Functional Mitochondrial Protein Levels in Plasma Neuron-Derived Extracellular Vesicles of Patients With Gadolinium Deposition
por: Goetzl, Edward J., et al.
Publicado: (2022)

Plasma tau in Alzheimer disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
por: Yao, Pamela J., et al.
Publicado: (2021)

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2021)

A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging
por: Li, Juan, et al.
Publicado: (2017)

TDP-43 Is Elevated in Plasma Neuronal-Derived Exosomes of Patients With Alzheimer’s Disease
por: Zhang, Nan, et al.
Publicado: (2020)

Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis
por: Goetzl, Edward J., et al.
Publicado: (2020)

Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States
por: Jiang, Yang, et al.
Publicado: (2016)

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
por: Tosun, Duygu, et al.
Publicado: (2021)

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
por: Motsinger-Reif, Alison A, et al.
Publicado: (2013)

Diagnostic Potential of Neural Exosome Cargo as Biomarkers for Acute Brain Injury
por: Goetzl, Laura, et al.
Publicado: (2017)

Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
por: Cai, Huimin, et al.
Publicado: (2022)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile
por: Winston, Charisse N., et al.
Publicado: (2016)

The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
por: Trombetta, Bianca A., et al.
Publicado: (2018)

Brain structure changes over time in normal and mildly impaired aged persons
por: Smith, Charles D, et al.
Publicado: (2020)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Nutrition and prevention of Alzheimer’s dementia
por: Swaminathan, Arun, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
por: Irwin, David J., et al.
Publicado: (2013)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

Current state of Alzheimer’s fluid biomarkers
por: Molinuevo, José Luis, et al.
Publicado: (2018)

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
por: Vemuri, Prashanthi, et al.
Publicado: (2011)

Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans
por: Elahi, Fanny M., et al.
Publicado: (2021)

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers
por: Lugli, Giovanni, et al.
Publicado: (2015)

Bladder antimuscarinics and cognitive decline in elderly patients
por: Moga, Daniela Claudia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3smo5uajgp5nv4s2qm4lej72eq